INVESTER I SEEGNAL MED ENDAVU: Køb Seegnal ($2I1) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Seegnal, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Seegnal Inc. is a healthcare technology company that provides software-as-a-service clinical decision support solutions for medication management and patient safety. The company focuses on reducing adverse drug effects and drug-related problems by delivering a patient-specific decision support platform that integrates with electronic medical records and other data sources to aggregate genetics, lab results, ECG readings, lifestyle factors, allergies, and current medications at the point of care. Seegnal’s platform functions as a prescription operating and intelligence layer, helping clinicians, hospitals, health systems, and insurers optimize prescribing quality and consistency in real time. Its enterprise-grade, AI-enhanced system is designed to minimize alert fatigue while providing precise, actionable insights to clinicians, supporting safer and more efficient clinical workflows. Seegnal Inc. operates through its Seegnal eHealth subsidiary and is headquartered in Calgary, Alberta, with its core SaaS platform actively marketed and deployed across multiple international healthcare markets. Founded in 2021 as a Canadian public company, Seegnal today plays a specialized role in the global health care technology sector.